Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksModel.php on line 57

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksController.php on line 62

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksController.php on line 64

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksController.php on line 66

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView.php on line 122

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView.php on line 125

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Settings.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Keyphrases.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Statistics.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Modules.php on line 16
alimta pemetrexed mesothelioma



Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell … (PR Newswire via Yahoo! Finance)

Eli Lilly and Company today announced that it has submitted an application with the European Medicines Agency for centralised review of ALIMTA® , in combination with cisplatin, for the first-line treatment of advanced non-small cell lung cancer .

More: continued here




   Posted in mesothelioma    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.






Leave a Reply